Filing Flows › Ensysce Biosciences (ENSC) › How it makes money
How Ensysce Biosciences (ENSC) makes money
Ensysce Biosciences (ENSC) made $1.2M of revenue in the second quarter 2026 (Q2 2026), -15% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $1.2M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $1.2M | -15% |
| Q1 2026 | $961K | -27% |
| Q4 2025 | $1.9M | +44% |
| Q3 2025 | $493K | -86% |
| Q2 2025 | $1.4M | +654% |
| Q1 2025 | $1.3M | +332% |
| Q4 2024 | $1.3M | +153% |
From Ensysce Biosciences' 10-Q filed Aug 13, 2026 (on EDGAR).
Questions
How does Ensysce Biosciences make money?
Ensysce Biosciences (ENSC) made $1.2M of revenue in the second quarter 2026 (Q2 2026), -15% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.